A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love. That’s what makes us Genentech! The newly formed Genetic Medicine Technology group in gRED (Genentech Research and Early Development) is redefining the future of cell and gene therapies. Our proprietary non-viral gene delivery and gene editing platforms, including lipid nanoparticles (LNPs), piggyBac® and Cas-CLOVER™, enable the development of next-generation CAR-T therapies with the potential to cure cancer and genetic diseases. We are seeking a highly motivated leader with a strong technical background in nanoparticle and LNP-mediated nucleic acids drug delivery. This person will join a dynamic and talented research team advancing non-viral therapies. This individual will direct efforts in developing novel non-viral drug delivery vehicles by overseeing the nanoparticle/nanotechnology function, working closely with the head of GMT. This individual will collaborate directly with immunology, bioanalytical, molecular biology, and pharmacology functions at Genentech San Diego to advance both platform and pipeline programs. This individual will also collaborate broadly with Genentech San Francisco and Roche research and innovation sites. The ideal candidate will have deep technical expertise with LNPs and chemistry, with additional expertise in pre-clinical models, xenographs, and T cell biology/manipulation.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees